Management of patients with type 1 diabetes in the hospital topical collection on hospital management of diabetes

Current Diabetes Reports

Volumn 14, Issue 2, 2014, Pages

  Yogi Morren, Divya ^a   Lansang, M Cecilia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Inpatient management of type 1 diabetes in the hospital; Type 1 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; PIG INSULIN; ANTIDIABETIC AGENT;

ARTICLE; CRITICALLY ILL PATIENT; DIABETIC KETOACIDOSIS; DIETARY INTAKE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN RESISTANCE; INTENSIVE CARE UNIT; NONHUMAN; PRACTICE GUIDELINE; DISEASE MANAGEMENT; HYPERGLYCEMIA; REVIEW;

DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; DISEASE MANAGEMENT; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN INFUSION SYSTEMS;

EID: 84895074002     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0458-9     Document Type: Article

References (31)

1. Daneman D. Type 1 diabetes. Lancet. 2006;367:847-58.
2. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia. 1999;42:1395-403.
3. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ. 2004;328:750-4.
4. Lambert AP, Gillespie KM, Thomson G, et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab. 2004;89:4037-43.
5. Umpierrez GE, Isaacs SD, Bazargan N, You X, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-82.
6. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-61.
7. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471-8.
8. Williams LS, Rotich J, Qi R, Fineberg N, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71.
9. Falciglia M, Freyberg RW, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Critical Care Med. 2009;37:3001-9.
10. Tewari S, Kathuria A, Meier-Kriesche H-U, et al. Association between admission hyperglycemia and length of stay after renal transplantation. Endocr Pract. 2010;16:805-9.
11. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New Engl J Med. 1993;329:977-86.
12. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. New Engl J Med. 2001;345:1359-67.
13. Malmberg K, Rydén L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
14. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diab Care. 2011;34:256-61. Important paper on basal bolus insulin therapy.
15. Shogbon AO, Levy SB. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia. Am J Health Syst Pharm. 2010;67:798-805.
16. Jacobsen IB, Henriksen JE, Hother-Nielsen O, et al. Evidence-based insulin treatment in type 1 diabetes mellitus. Diabetes Res Clin Pract. 2009;86:1-10.
17. Standards of medical care in diabetes - 2013. American Diabetes Association. Diab Care. 2013;36(Suppl 1):S11-66.
18. Vella S, Buetow L, Royle P, et al. The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia. 2010;53:809-20.
19. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, et al. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes. 1999;48:1593-9.
20. Pang TTL, Narendran P. Addressing insulin resistance in Type 1 diabetes. Diabetic Med. 2008;25:1015-24.
21. Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev. 2002;18:114-7.
22. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16-38.
23. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353-69.
24. Clement S, Braithwaite SS, Magee MF, Ahmann A, et al. Management of diabetes and hyperglycemia in hospitals. Diab Care. 2004;27:553-91.
25. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006;12:458-68.
26. Dates R, Origin DO. Medical policy No. 91516-R5. Medical errors: serious reportable events. 2006;91516:1-13.
27. Vann MA. Perioperative management of ambulatory surgical patients with diabetes mellitus. Curr Opin Anesth. 2009;22:718-24.
28. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diab Care. 2009;32:1335-43. Important paper describing the presentation, pathogenesis, diagnosis, and management of DKA.
29. Beck RW, Tamborlane WV, Bergenstal RM, et al. The T1D Exchange clinic registry. J Clin Endocrinol Metab. 2012;97:4383-9.
30. Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. New Engl J Med. 2012;366:1616-24. Important paper on insulin pump therapy in T1DM.
31. Grunberger G, Bailey TS, Cohen AJ, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16:746-62.